2811. Real-World Experience Utilizing Cefiderocol for Serious Multidrug Resistant Gram-Negative Infections

BACKGROUND: Cefiderocol is a novel siderophore cephalosporin that demonstrated in vitro activity against carbapenem-resistant Enterobacterales, Acinetobacter baumannii (AB), Pseudomonas aeruginosa (PA), and Stenotrophomonas maltophilia. Cefiderocol demonstrated promising efficacy in randomized, clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Teran, Nicholas S, Zidaru, Andrei, Phe, Kady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679052/
http://dx.doi.org/10.1093/ofid/ofad500.2422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679052/
http://dx.doi.org/10.1093/ofid/ofad500.2422

Ejemplares similares